Suche

Programmdetails

Postervorträge

Aortenstenose und Aorteninsuffizienz – Behandlung und Outcomeparameter

Freitag, 5. April | 09:45 - 11:15 Uhr | Posterbereich 5

Vorsitz/Chair: Vera Oettinger (Freiburg im Breisgau), Wolfgang Schöls (Duisburg)

Agenda

(P1233)
Propensity-Matched Comparison of JenaValve Trilogy System Versus SAPIEN 3 Ultra Transcatheter Heart Valves in Patients with Severe Aortic Valve Stenosis
H. S. Wienemann (Köln)
(P1234)
Performance of Sapien 3 ultra and Sapien 3 29 mm transcatheter heart valves in bicuspid versus tricuspid calcific aortic valve stenosis
G. Alothman (Dresden)
(P1235)
Transcatheter aortic valve replacement in patients with severe aortic valve stenosis and concomitant mitral valve regurgitation – 5 years follow-up
R. H. Rangel (Kiel)
(P1236)
Sex differences in transfemoral transcatheter aortic valve implantation for severe aortic regurgitation
H. S. Wienemann (Köln)
(P1237)
Superior role of global longitudinal strain in predicting cardiac performance after aortic valve repair in severe aortic regurgitation
X. Hua (Hamburg)
(P1238)
Quantitative and Functional Evaluation of Both Ventricles Following the Ross Procedure Compared to Conventional Aortic Valve Surgery
X. Hua (Hamburg)
(P1239)
How to identify patients at risk for fast progressive aortic stenosis?
M. Senel (Tübingen)
(P1240)
Clinical Outcomes of Transcatheter Aortic Valve Implantation in Patients with Significant Septal Hypertrophy
M. Beyer (Hamburg)
(P1241)
Cardiac power output or stroke volume index to predict outcome in transcatheter aortic valve implantation
N. Mangner (Dresden)
Diese Seite teilen